Schroder Investment Management Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Schroder Investment Management Group’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-73,694	Closed	-$2.83M	–	1525
2020 Q3	$2.83M	Sell	73,694 -103,448	-58%	-$4.5M	﹤0.01%	835
2020 Q2	$7.52M	Sell	177,142 -35,514	-17%	-$2.39M	0.01%	621
2020 Q1	$16.6M	Sell	212,656 -11,192	-5%	-$896K	0.04%	415
2019 Q4	$20.7M	Buy	+223,848	New	+$18.9M	0.03%	486

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Schroder Investment Management Group's EVFM Position: Q4 2020 in Review

Schroder Investment Management Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020, closing a stake of 73,694 shares — an estimated $2.83M sold.

Schroder Investment Management Group first reported a position in EVFM in Q4 2019 and held it in 4 quarters. The position peaked at $20.7M in Q4 2019. 93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

Schroder Investment Management Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Schroder Investment Management Group sold 73,694 Evofem Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $2.83M.
Schroder Investment Management Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Schroder Investment Management Group's Evofem Biosciences, Inc. Common Stock position peaked at $20.7M in Q4 2019.
93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on Schroder Investment Management Group's 13F filing for Q4 2020, filed 16 Feb 2021.